• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD
United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others - Product Image

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

  • ID: 2132414
  • May 2012
  • Region: United States
  • 197 pages
  • GlobalData

FEATURED COMPANIES

  • Accuray Incorporated
  • CareFusion Corporation
  • Cyberonics, Inc.
  • Elekta AB
  • Medtronic, Inc.
  • St. Jude Medical, Inc.
  • MORE

United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others

Summary

GlobalData’s new report, “United States Neurology Devices Market Outlook to 2018 - Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices and Others” provides key market data on the United States Neurology Devices market. The report provides value (USD million), volume (units) and average price (USD) data for each segment and sub-segment within six market categories – CSF Management, Interventional Neurology, Neurological Diagnostic Equipment, Neurostimulation Devices, Neurosurgical Products and Radiosurgery. The report also provides company shares and distribution shares data for each of the aforementioned market categories. The report is supplemented with global corporate-level profiles of the key market participants with information on company financials and pipeline products, wherever available.

This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData’s READ MORE >

FEATURED COMPANIES

  • Accuray Incorporated
  • CareFusion Corporation
  • Cyberonics, Inc.
  • Elekta AB
  • Medtronic, Inc.
  • St. Jude Medical, Inc.
  • MORE

1
1

1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What is This Report About?
3 Neurology Devices In United States
3.1 Neurology Devices, Market Segmentation
3.2 Neurology Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018
3.3 Neurology Devices Market, United States, Revenue Mix ($m), 2011
3.4 Neurology Devices Market, United States, Category Contribution (%), 2011
3.5 Neurology Devices, United States, Company Share (2010-2011)
4 CSF Management In United States
4.1 CSF Management, Market Segmentation
4.2 CSF Management Market, United States, Revenue Mix ($m), 2011
4.3 CSF Management Market, United States, Segment Contribution (%), 2011
4.4 CSF Management Overall Revenue, (2004-2018)
4.5 CSF Management Overall Volume (2004-2018)
4.6 CSF Management Average Price (2004-2018)
4.7 CSF Management Distribution Share (2010-2011)
4.8 CSF Management, United States, Company Share (2010-2011)
5 Interventional Neurology In United States
5.1 Interventional Neurology, Market.Segmentation
5.2 Interventional Neurology Market, United States, Revenue Mix ($m), 2011
5.3 Interventional Neurology Market, United States, Segment Contribution (%), 2011
5.4 Interventional Neurology Overall Revenue, (2004-2018)
5.4.1 Embolic Systems Revenue (2004-2018)
5.4.2 Navigational Systems Revenue (2004-2018)
5.5 Interventional Neurology Overall Volume (2004-2018)
5.5.1 Embolic Systems Volume (2004-2018)
5.5.2 Navigational Systems Volume (2004-2018)
5.6 Interventional Neurology Average Price (2004-2018)
5.7 Interventional Neurology Distribution Share (2010-2011)
5.8 Interventional Neurology, United States, Company Share (2010-2011)
6 Neurological Diagnostic Equipment In United States
6.1 Neurological Diagnostic Equipment, Market.Segmentation
6.2 Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2011
6.3 Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2011
6.4 Neurological Diagnostic Equipment Overall Revenue, (2004-2018)
6.5 Neurological Diagnostic Equipment Overall Volume (2004-2018)
6.6 Neurological Diagnostic Equipment Average Price (2004-2018)
6.7 Neurological Diagnostic Equipment Distribution Share (2010-2011)
6.8 Neurological Diagnostic Equipment, United States, Company Share (2010-2011)
7 Neurostimulation Devices In United States
7.1 Neurostimulation Devices, Market Segmentation
7.2 Neurostimulation Devices Market, United States, Revenue Mix ($m), 2011
7.3 Neurostimulation Devices Market, United States, Segment Contribution (%), 2011
7.4 Neurostimulation Devices Overall Revenue, (2004-2018)
7.5 Neurostimulation Devices Overall Volume (2004-2018)
7.6 Neurostimulation Devices Average Price (2004-2018)
7.7 Neurostimulation Devices Distribution Share (2010-2011)
7.8 Neurostimulation Devices, United States, Company Share (2010-2011)
8 Neurosurgical Products In United States
8.1 Neurosurgical Products, Market Segmentation
8.2 Neurosurgical Products Market, United States, Revenue Mix ($m), 2011
8.3 Neurosurgical Products Market, United States, Segment Contribution (%), 2011
8.4 Neurosurgical Products Overall Revenue, (2004-2018)
8.5 Neurosurgical Products Overall Volume (2004-2018)
8.6 Neurosurgical Products Average Price (2004-2018)
8.7 Neurosurgical Products Distribution Share (2010-2011)
8.8 Neurosurgical Products, United States, Company Share (2010-2011)
9 Radiosurgery In United States
9.1 Radiosurgery, Market Segmentation
9.2 Radiosurgery Market, United States, Revenue Mix ($m), 2011
9.3 Radiosurgery Market, United States, Segment Contribution (%), 2011
9.4 Radiosurgery Overall Revenue, (2004-2018)
9.5 Radiosurgery Overall Volume (2004-2018)
9.6 Radiosurgery Average Price (2004-2018)
9.7 Radiosurgery Distribution Share (2010-2011)
9.8 Radiosurgery, United States, Company Share (2010-2011)
10 Overview of Key Companies in United States Neurology Devices Market
10.1 Medtronic, Inc.
10.1.1 Company Overview
10.1.2 Share in the United States Neurology Devices Market
10.2 Boston Scientific Corporation
10.2.1 Company Overview
10.2.2 Share in the United States Neurology Devices Market
10.3 St. Jude Medical, Inc.
10.3.1 Company Overview
10.3.2 Share in the United States Neurology Devices Market
10.4 Cyberonics, Inc.
10.4.1 Company Overview
10.4.2 Share in the United States Neurology Devices Market
10.5 DePuy, Inc.
10.5.1 Company Overview
10.5.2 Share in the United States Neurology Devices Market
10.6 Stryker Corporation
10.6.1 Company Overview
10.6.2 Share in the United States Neurology Devices Market
10.7 Accuray Incorporated
10.7.1 Company Overview
10.8 Integra LifeSciences Holdings Corporation
10.8.1 Company Overview
10.9 Cadwell Laboratories, Inc.
10.9.1 Company Overview
10.10 CareFusion Corporation
10.10.1 Company Overview
10.11 Elekta AB
10.11.1 Company Overview
10.12 Natus Medical Incorporated
10.12.1 Company Overview
10.13 B. Braun Melsungen AG
10.13.1 Company Overview
10.14 Nihon Kohden Corporation
10.14.1 Company Overview
10.15 Terumo Corporation
10.15.1 Company Overview
10.16 KARL STORZ GmbH & Co. KG
10.16.1 Company Overview
10.17 Christoph Miethke GmbH & Co. KG
10.17.1 Company Overview
10.18 Covidien plc
10.18.1 Company Overview
11 Neurology Devices Market Pipeline Products
12 Financial Deals Landscape
12.1 Acquisition
12.1.1 Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company
12.1.2 Baxter International Completes Acquisition Of Synovis Life Technologies For $325 Million
12.1.3 NuVasive Completes Acquisition Of Impulse Monitoring For $80 Million
12.1.4 Stryker Completes Acquisition Of Concentric Medical For $135 Million
12.1.5 Zynex Completes Acquisition Of NeuroDyne Medical
12.1.6 LecTec Completes Acquisition Of AxoGen In Reverse Acquisition
12.1.7 Toshiba Medical Systems Completes Acquisition Of Vital Images For $273 Million
12.2 Partnerships
12.2.1 Sequent Medical Enter Into Licensing Agreement With Inceptus Medical For MicroBraid Technology
12.2.2 GE Healthcare Enters Into A Distribution Agreement With KC BioMedix
12.2.3 Radiant Sage Forms Joint Venture With Radiological Associates
12.2.4 NSVascular Enters Into Licensing Agreement With University of California
13 Recent Developments
13.1 Strategy And Business Planning
13.1.1 Feb 27, 2012: Greatbatch Announces Engagement To Advance Medical Device Strategy
13.1.2 Feb 22, 2012: Accelitech To Open First CyberKnife Cancer Center Within City Of Chicago
13.1.3 Feb 09, 2012: Zynex Forms European Subsidiary
13.1.4 Jan 31, 2012: Boston Scientific Announces New Asia-Pacific Organization
13.1.5 Jan 21, 2012: CareFusion Opens Middle East Office In Dubai
13.1.6 Jan 10, 2012: Lanx Announces Corporate Expansion
13.1.7 Dec 19, 2011: Medical Centers Worldwide Adopt Both Accuray's CyberKnife And TomoTherapy Systems
13.1.8 Dec 05, 2011: Integra LifeSciences Establishes First Office In Shanghai, China
13.1.9 Dec 01, 2011: InVivo Therapeutics Executes Deal For New, World-Class Global Corporate Headquarters Including Research And cGMP Manufacturing Facilities
13.1.10 Nov 09, 2011: Allied Minds Forms New Company Focused On Medtech Product Commercialization
13.1.11 Nov 08, 2011: Allergan To Open New Research And Development Facility In New Jersey
13.1.12 Nov 02, 2011: Accellent Opens New Manufacturing Plant In Penang, Malaysia
13.1.13 Oct 13, 2011: Unisense Establishes US Headquarter
13.2 Legal and Regulatory
13.2.1 Mar 30, 2012: Medtronic Reaches Settlement Of Shareholder Class Action
13.2.2 Jan 17, 2012: Levi & Korsinsky Announces Investigation Against Integra LifeSciences
13.2.3 Dec 13, 2011: Medtronic Reaches Settlement With US Department of Justice
13.2.4 Dec 07, 2011: Boston Scientific Receives Notice Of Deficiency From IRS
13.2.5 Oct 14, 2011: Boston Scientific Welcomes Introduction Of Medical Device Regulatory Improvement Act In US Senate
13.2.6 Aug 08, 2011: Faruqi & Faruqi Announces Investigation Against Zynex
13.2.7 May 24, 2011: Jensen Law Firm Announces $10m Verdict Against Johnson & Johnson Unit For Toxic Motrin Reaction
13.2.8 May 03, 2011: U.S. Senate Finance Committee Announces Investigation Against Medtronic
13.2.9 Apr 25, 2011: St. Jude Medical Wins $2.3 Billion In Trade Secret Infringement Lawsuit Against Nervicon
13.3 Product News
13.3.1 Sep 26, 2011: Elekta To Showcase Its Products At 2011 ASTRO Meeting In Florida
13.3.2 Aug 10, 2010: NKI To Present Two Research Studies On I-Portal NOTC System At Barany Society Conference
13.3.3 May 05, 2010: Terumo Announces Its Program For The Global Embolization Symposium And Technologies (GEST) Meeting
13.3.4 Mar 09, 2010: MIT Selects Elekta Neuromag To Explore Brain Function
13.3.5 Mar 01, 2010: Integra Launches OSV II Lumbar And OSV II Low Flow Lumbar Self-Adjusting Valves
13.3.6 Feb 23, 2010: Barnes-Jewish Hospital Treats More Patients With Elekta’s Extend Program For Gamma Knife Perfexion
13.4 Government and Public Interest
13.4.1 Apr 18, 2012: Researchers Discover Non-Surgical Test For Brain Cancer
13.4.2 Apr 16, 2012: Mechanical Tissue Resuscitation Technology Shows Promise: Wake Forest Baptist Medical Center
13.4.3 Mar 30, 2012: CareFusion Showcases Solutions To Improve Operating Room Effectiveness At AORN Congress 2012
13.4.4 Mar 21, 2012: Neuro Kinetics To Preview Updated I-Portal Technology & VEST Software At American Academy of Audiology Conference
13.4.5 Mar 12, 2012: NeuroMetrix To Exhibit At 2012 Diabetic Foot Global Conference
13.4.6 Mar 12, 2012: NeuroMetrix To Exhibit At 2012 Diabetic Foot Global Conference
13.4.7 Mar 04, 2012: Study Shows Brain Flexibility, Gives Hope For Natural-Feeling Neuroprosthetics
13.4.8 Feb 23, 2012: ZOLL Sponsors Latin America’s First Symposium On Therapeutic Temperature Management
13.4.9 Feb 10, 2012: EEG Pattern Reflects Brain's Shift Into Low-Energy, Protective Mode: MGH
13.4.10 Feb 02, 2012: New Procedure Repairs Severed Nerves In Minutes, Restoring Limb Use In Days Or Weeks
13.4.11 Jan 24, 2012: New Deep Brain Stimulation Device Shows Promising Results: University of Cincinnati
13.4.12 Jan 20, 2012: CareFusion Provides Update On Voluntary Recall Of Neurological Monitoring Software And Devices
13.4.13 Jan 20, 2012: New Imaging Techniques Prove Valuable Tools To Assess Stroke Risk: Vanderbilt University
13.4.14 Jan 12, 2012: CSHL Team Introduces Automated Imaging To Greatly Speed Whole-Brain Mapping Efforts
13.4.15 Jan 02, 2012: Schizophrenia Diagnosis Associated With Progressive Brain Changes Among Adolescents: Study
13.4.16 Jan 02, 2012: Deep Brain Stimulation Shows Promising Results For Unipolar And Bipolar Depression: Study
13.4.17 Dec 21, 2011: UCLA Neuroscientists Demonstrate Crucial Advances In 'Brain Reading'
13.4.18 Nov 28, 2011: Functional Brain Pathways Disrupted In Children With ADHD
13.4.19 Nov 25, 2011: Deymed Diagnostic To Participate In Arab Health 2012 Conference
13.4.20 Nov 17, 2011: NREF And OREF Announce Creation Of Collaborative Spine Research Foundation To Fund Spine-Care Research
13.4.21 Nov 13, 2011: Ultrathin Flexible Brain Implant Offers Unique Look At Seizures In NIH-Funded Research
13.4.22 Nov 02, 2011: Lake Region Medical To Showcase New And Emerging Technologies At TCT Annual Meeting 2011
14 Appendix
14.1 Definitions of Markets Covered in the Report
14.1.1 Neurology Devices
14.2 Research Methodology
14.3 Secondary Research
14.4 Primary Research
14.5 Models
14.6 Forecasts
14.7 Expert Panels
14.8 GlobalData Consulting
14.9 Contact Us
14.10 Disclaimer

1.1 List of Tables
Table 1: Neurology Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018
Table 2: Neurology Devices Market, United States, Category Contribution (%), 2011
Table 3: Neurology Devices, United States, Cross-Category Analysis, 2004-2018
Table 4: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Table 5: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Table 6: Neurology Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 7: CSF Management Market, United States, Segment Contribution (%), 2011
Table 8: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 9: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 10: CSF Management, United States, Volume (Units) by Segment, Historic, 2004-2011
Table 11: CSF Management, United States, Volume (Units) by Segment, Forecast, 2011-2018
Table 12: CSF Management, United States, Average Price ($), Historic, 2004-2011
Table 13: CSF Management, United States, Average Price ($), Forecast, 2011-2018
Table 14: CSF Management, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 15: CSF Management, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 16: Interventional Neurology Market, United States, Segment Contribution (%), 2011
Table 17: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 18: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 19: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 20: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 21: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Table 22: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Table 23: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2004-2011
Table 24: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2011-2018
Table 25: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 26: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 27: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011
Table 28: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Table 29: Interventional Neurology, United States, Average Price ($), Historic, 2004-2011
Table 30: Interventional Neurology, United States, Average Price ($), Forecast, 2011-2018
Table 31: Interventional Neurology, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 32: Interventional Neurology, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 33: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2011
Table 34: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 35: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 36: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2004-2011
Table 37: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2011-2018
Table 38: Neurological Diagnostic Equipment, United States, Average Price ($), Historic, 2004-2011
Table 39: Neurological Diagnostic Equipment, United States, Average Price ($), Forecast, 2011-2018
Table 40: Neurological Diagnostic Equipment, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 41: Neurological Diagnostic Equipment, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 42: Neurostimulation Devices Market, United States, Segment Contribution (%), 2011
Table 43: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 44: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 45: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2004-2011
Table 46: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018
Table 47: Neurostimulation Devices, United States, Average Price ($), Historic, 2004-2011
Table 48: Neurostimulation Devices, United States, Average Price ($), Forecast, 2011-2018
Table 49: Neurostimulation Devices, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 50: Neurostimulation Devices, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 51: Neurosurgical Products Market, United States, Segment Contribution (%), 2011
Table 52: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 53: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 54: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2004-2011
Table 55: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2011-2018
Table 56: Neurosurgical Products, United States, Average Price ($), Historic, 2004-2011
Table 57: Neurosurgical Products, United States, Average Price ($), Forecast, 2011-2018
Table 58: Neurosurgical Products, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 59: Neurosurgical Products, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 60: Radiosurgery Market, United States, Segment Contribution (%), 2011
Table 61: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Table 62: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Table 63: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2004-2011
Table 64: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2011-2018
Table 65: Radiosurgery, United States, Average Price ($), Historic, 2004-2011
Table 66: Radiosurgery, United States, Average Price ($), Forecast, 2011-2018
Table 67: Radiosurgery, United States, Distribution Share by Revenue ($m), USD Constant, 2010-2011
Table 68: Radiosurgery, United States, Company Share by Revenue ($m), USD Constant, 2010-2011
Table 69: Neurology Devices Market Pipeline Products
Table 70: Greatbatch Acquires NeuroNexus Technologies, Neurotechnology Company
Table 71: Baxter International Completes Acquisition Of Synovis Life Technologies For $325 Million
Table 72: NuVasive Completes Acquisition Of Impulse Monitoring For $80 Million
Table 73: Stryker Completes Acquisition Of Concentric Medical For $135 Million
Table 74: Zynex Completes Acquisition Of NeuroDyne Medical
Table 75: LecTec Completes Acquisition Of AxoGen In Reverse Acquisition
Table 76: Toshiba Medical Systems Completes Acquisition Of Vital Images For $273 Million
Table 77: Sequent Medical Enter Into Licensing Agreement With Inceptus Medical For MicroBraid Technology
Table 78: GE Healthcare Enters Into A Distribution Agreement With KC BioMedix
Table 79: Radiant Sage Forms Joint Venture With Radiological Associates
Table 80: NSVascular Enters Into Licensing Agreement With University of California

1.2 List of Figures
Figure 1: Neurology Devices, Market Segmentation
Figure 2: Neurology Devices, United States, Overall Revenue ($m), USD Constant, 2004-2018
Figure 3: Neurology Devices Market, United States, Revenue Mix ($m), 2011
Figure 4: Neurology Devices Market, United States, Category Contribution (%), 2011
Figure 5: Neurology Devices, United States, Cross-Category Analysis, 2004-2018
Figure 6: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Historic, 2004-2011
Figure 7: Neurology Devices, United States, Overall Revenue ($m), USD Constant, Forecast, 2011-2018
Figure 8: Neurology Devices, United States, Company Share (%), 2011
Figure 9: CSF Management, Market Segmentation
Figure 10: CSF Management Market, United States, Revenue Mix ($m), 2011
Figure 11: CSF Management Market, United States, Segment Contribution (%), 2011
Figure 12: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 13: CSF Management, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 14: CSF Management, United States, Volume (Units) by Segment, Historic, 2004-2011
Figure 15: CSF Management, United States, Volume (Units) by Segment, Forecast, 2011-2018
Figure 16: CSF Management, United States, Company Share (%), 2011
Figure 17: Interventional Neurology, Market Segmentation
Figure 18: Interventional Neurology Market, United States, Revenue Mix ($m), 2011
Figure 19: Interventional Neurology Market, United States, Segment Contribution (%), 2011
Figure 20: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 21: Interventional Neurology, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 22: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 23: Embolic Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 24: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Historic, 2004-2011
Figure 25: Navigational Systems, United States, Revenue ($m) USD Constant, by Sub-Segment, Forecast, 2011-2018
Figure 26: Interventional Neurology, United States, Volume (Units) by Segment, Historic, 2004-2011
Figure 27: Interventional Neurology, United States, Volume (Units) by Segment, Forecast, 2011-2018
Figure 28: Embolic Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 29: Embolic Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 30: Navigational Systems, United States, Volume (Units) by Sub-Segment, Historic, 2004-2011
Figure 31: Navigational Systems, United States, Volume (Units) by Sub-Segment, Forecast, 2011-2018
Figure 32: Interventional Neurology, United States, Company Share (%), 2011
Figure 33: Neurological Diagnostic Equipment, Market Segmentation
Figure 34: Neurological Diagnostic Equipment Market, United States, Revenue Mix ($m), 2011
Figure 35: Neurological Diagnostic Equipment Market, United States, Segment Contribution (%), 2011
Figure 36: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 37: Neurological Diagnostic Equipment, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 38: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Historic, 2004-2011
Figure 39: Neurological Diagnostic Equipment, United States, Volume (Units) by Segment, Forecast, 2011-2018
Figure 40: Neurological Diagnostic Equipment, United States, Company Share (%), 2011
Figure 41: Neurostimulation Devices, Market Segmentation
Figure 42: Neurostimulation Devices Market, United States, Revenue Mix ($m), 2011
Figure 43: Neurostimulation Devices Market, United States, Segment Contribution (%), 2011
Figure 44: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 45: Neurostimulation Devices, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 46: Neurostimulation Devices, United States, Volume (Units) by Segment, Historic, 2004-2011
Figure 47: Neurostimulation Devices, United States, Volume (Units) by Segment, Forecast, 2011-2018
Figure 48: Neurostimulation Devices, United States, Company Share (%), 2011
Figure 49: Neurosurgical Products, Market Segmentation
Figure 50: Neurosurgical Products Market, United States, Revenue Mix ($m), 2011
Figure 51: Neurosurgical Products Market, United States, Segment Contribution (%), 2011
Figure 52: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 53: Neurosurgical Products, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 54: Neurosurgical Products, United States, Volume (Units) by Segment, Historic, 2004-2011
Figure 55: Neurosurgical Products, United States, Volume (Units) by Segment, Forecast, 2011-2018
Figure 56: Neurosurgical Products, United States, Company Share (%), 2011
Figure 57: Radiosurgery, Market Segmentation
Figure 58: Radiosurgery Market, United States, Revenue Mix ($m), 2011
Figure 59: Radiosurgery Market, United States, Segment Contribution (%), 2011
Figure 60: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Historic, 2004-2011
Figure 61: Radiosurgery, United States, Revenue ($m) USD Constant, by Segment, Forecast, 2011-2018
Figure 62: Radiosurgery, United States, Volume (Units) by Segment, Historic, 2004-2011
Figure 63: Radiosurgery, United States, Volume (Units) by Segment, Forecast, 2011-2018
Figure 64: Radiosurgery, United States, Company Share (%), 2011
Figure 65: Medtronic, Inc., Company Share (%),United States Neurology Devices Market, 2011
Figure 66: Boston Scientific Corporation, Company Share (%),United States Neurology Devices Market, 2011
Figure 67: St. Jude Medical, Inc., Company Share (%),United States Neurology Devices Market, 2011
Figure 68: Cyberonics, Inc., Company Share (%),United States Neurology Devices Market, 2011
Figure 69: DePuy, Inc., Company Share (%),United States Neurology Devices Market, 2011
Figure 70: Stryker Corporation, Company Share (%),United States Neurology Devices Market, 2011

Medtronic, Inc.
Boston Scientific Corporation
St. Jude Medical, Inc.
Cyberonics, Inc.
DePuy, Inc.
Stryker Corporation
Accuray Incorporated
Integra LifeSciences Holdings Corporation
Cadwell Laboratories, Inc.
CareFusion Corporation
Elekta AB
Natus Medical Incorporated
B. Braun Melsungen AG
Nihon Kohden Corporation
Terumo Corporation
KARL STORZ GmbH & Co. KG
Christoph Miethke GmbH & Co. KG
Covidien plc

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos